Inhibition of ATR is also shown to strongly synergise with these low doses of gemcitabine (Huntoon et al., 2013; Prevo et al., 2012; Wallez et al., 2018), whereas we found that only higher concentrations (> 1 mm) of HU sensitised melanoma TSs to ATR inhibition. Here, ATR is linked to melanoma.